Overview

Corticosteroid Reduction in COPD

Status:
Completed

Trial end date:
2019-01-01

Target enrollment:

Participant gender:

Summary

This study explores whether patients hospitalized with chronic obstructive pulmonary disease (COPD) exacerbation may have fewer days with prednisolone and with the same treatment effect by controlling the treatment by daily measurements of eosinophils.

Phase:

Phase 4

Details

Lead Sponsor:

Chronic Obstructive Pulmonary Disease Trial Network, Denmark

Treatments:

Methylprednisolone
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate